Stability of the toric Intraocular lens in combined microincision vitrectomy and phacoemulsification with C3F8 injection

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400081222

Enrollment

Unknown

Registered

2024-02-26

Start date

2024-02-26

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular hole, rhegmatogenous retinal detachment, vitreous hemorrhage, diabetes retinopathy, vitreous opacity, macular epiretinal membrane,astigmatism

Interventions

Experimental group:combined vitrectomy and phacoemulsification with C3F8 injection and toric intraocular lens implantation(Zeiss Torbi 709 M)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1: Diagnosed with macular hole, rhegmatogenous retinal detachment, vitreous hemorrhage, diabetes retinopathy, vitreous opacity, macular epiretinal membrane, and corneal regular astigmatism greater than 1.0D 2: Patients who require combined vitrectomy and phacoemulsification with C3F8 injection 3: Agree to implant toric intraocular lens(Zeiss Torbi 709 M) 4: Age greater than 18 years old

Exclusion criteria

Exclusion criteria: 1: Accompanied by other retinal diseases 2: eye axial length>26mm

Design outcomes

Primary

Measure	Time frame
rotation degree of toric intraocular lens;position of toric intraocular lens;uncorrected visual acuity;	—

Secondary

Measure	Time frame
best correction of visual acuity;intraocular pressure;axial length;astigmatism diopters;	—

Countries

China

Contacts

Public ContactXiubin Ma

Qingdao Eye Hospital Affiliated to Shandong First Medical University

maxiubin2005@126.com+86 185 6130 1747

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026